Concert Pharmaceuticals Inc
CNCE
Get informed when a big investor buys or sells
+ FollowMarket Cap$0
Close$
$12.52
49.6% upside
Current Fair Value
49.6% upsideUndervalued by 49.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $-73,381,000.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.4 |
| Beta | 0.52 |
| Outstanding Shares | 49,731,000 |
Return
| Return on Equity | -49.86% |
|---|---|
| Return on Assets | -38.83% |
| Return on Invested Capital | -44.71% |
Valuation & Multiples
| P/E Ratio | -3.49 |
|---|---|
| PEG | -61.03 |
| Price to Sales | - |
| Price to Book Ratio | 4.19 |
| Enterprise Value to Revenue | -1296.99 |
| Enterprise Value to EBIT | 1.07 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | -0.3 |
| Debt to Equity | 0.16 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Concert Pharmaceuticals Inc
CEO: Roger Tung